Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Empresa británica ofrece una nueva sonda de imagen molecular fluorescente a compañías que utilicen tecnología de imagen fluorescente en sus productos y flujos de trabajo

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOUK20181129001
Publicado:
05/12/2018
Caducidad:
06/12/2019
Resumen:
Una pyme británica ha desarrollado una tecnología de imagen molecular fluorescente para investigación biológica y médica. El uso de sondas fluorescentes es una parte esencial de la investigación biológica y ofrece una herramienta primordial en investigación médica. Las sondas fluorescentes se emplean para detectar y monitorizar moléculas de interés dentro de células y tejidos, entre otras aplicaciones. Las nanopartículas poliméricas conjugadas desarrolladas por la empresa contienen un núcleo polimérico que emite luz semiconductora, encapsulado dentro de un surfactante. Estas partículas son más brillantes y estables que la tecnología actual (fluoróforos y puntos cuánticos), siendo más sensibles. La empresa ofrece nanopartículas poliméricas conjugadas a compañías que utilicen sondas fluorescentes en sus productos, servicios y flujos de trabajo para alcanzar nuevos mercados y continuar con el desarrollo de sus tecnologías. La cooperación se establecerá en el marco de un acuerdo de cooperación técnica.

Details

Tittle:
UK-based SME offers its novel fluorescent molecular imaging probe technology to companies using fluorescent imaging in their products and workflows under a technical cooperation
Summary:
A UK-based SME has developed novel fluorescent molecular imaging technology for biological and medical science research. They are offering their conjugated polymer nanoparticles to companies that are using fluorescent probes in their products, services or workflows to reach new markets and further develop their technology. It is envisaged that the partnership will take the form of a technical cooperation agreement.
Description:
The use of fluorescent probes is an essential part of biological science research and provides a vital tool for medical research. They are used to detect and monitor molecules of interest within cells and tissues among other applications. However, the technology currently used has not developed much since the 1980´s and has several flaws that limit effectiveness. This includes limited brightness, photobleaching, and poor stability of current fluorescent probes, which restricts sensitivity.

A UK-based SME has developed a novel fluorescent molecular imaging probe technology that overcomes these limitations. They have developed conjugated polymer nanoparticles containing a semiconductor light emitting polymer core, encapsulated within a surfactant. These particles are brighter and more stable than currently used technology such as fluorophores and quantum dots, making them more sensitive. They are also non-toxic so can be used in live cell and tissue imaging as well as in in vivo experiments. These particles can also incorporate a magnetic core enabling additional functions such as sample purification. The particles can be used in existing methodologies (fluorescent microscopy, flow cytometry, immunohisto/cytochemistry, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, lateral flow diagnostics etc.) with no changes to protocols needed.

The UK-based SME is looking to further develop this technology and enter new markets. They are therefore offering their conjugated polymer nanoparticles to companies that are using or plan to use existing fluorescent imaging probes in their products or services and workflows. The SME would like feedback from partner companies on the use of their nanoparticles in products and workflows so they can further adapt and develop the technologies to add to their portfolio. It is envisaged that the partnership will take the form of a technical cooperation but other partnerships will be considered depending on individual circumstances.
Advantages and Innovations:
The UK-based SME´s novel conjugated polymer nanoparticle imaging probes have the following advantages:

1. High degree of photostability preventing loss of signal due to photobleaching.
2. Highly specific targeting.
3. Non-toxic enabling normal cell and tissue function to be studied.
4. Compatible with current molecular detection systems (fluorescent microscopy, flow cytometry, immunohisto/cytochemistry, ELISA, Rapid Diagnostic Tests, lateral flow diagnostics etc.)
5. Can be used in vivo and in vitro with no changes to existing, established protocols.
6. Magnetic core capability enables modal imaging and magnetic sample purification.
7. 1400x brighter than existing alexa fluorophores, 200x brighter than Quantum Dots.
8. Four wavelengths can be produced at scale with a further four wavelengths in development and will be available in 2019.
Stage of Development:
Already on the market
IPs:
Secret Know-how,Patents granted

Partner sought

Type and Role of Partner Sought:
The UK-based SME is looking to partner with companies who are using, or are looking to use, fluorescent imaging probes in their products or systems. The UK-based SME will offer their unique conjugated polymer nanoparticles to partner companies to incorporate into their systems, products and workflows. They would expect feedback from the partner companies in relation to the performance of the conjugated polymer nanoparticles in their products and workflows in order to inform further development of the existing conjugated polymer nanoparticles and introduction of new product lines. It is envisaged that the partnership will take the form of a technical cooperation agreement although other partnerships will be considered dependent on circumstances.

Client

Type and Size of Client:
Industry SME <= 10
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English

Keywords

Technology Keywords:
06002001 Bioquímica / biofísica
06002009 Diseño molecular
06002007 Ensayos in vitro, experimentos